Human immunopathogenesis of severe acute respiratory syndrome (SARS)
暂无分享,去创建一个
Ali Danesh | Mark J Cameron | M. Cameron | D. Kelvin | A. Danesh | M. Muller | David J Kelvin | J. Bermejo‐Martin | Matthew P Muller | Jesus F Bermejo-Martin | J. Bermejo-Martín
[1] Michel Theron,et al. An interferon‐γ‐related cytokine storm in SARS patients† , 2004, Journal of medical virology.
[2] A. Takaoka,et al. Interferon signalling network in innate defence , 2006, Cellular microbiology.
[3] J. Sung,et al. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study , 2003, BMJ : British Medical Journal.
[4] Mark Chappell,et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.
[5] K. Kain,et al. Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by Coronavirus , 2005, The Journal of infectious diseases.
[6] Qingling Zhang,et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways , 2004, The Journal of pathology.
[7] Arthur S Slutsky,et al. Critically ill patients with severe acute respiratory syndrome. , 2003, JAMA.
[8] Elizabeth Rea,et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. , 2003, JAMA.
[9] Yi Guan,et al. Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.
[10] A. Mandavilli. Open season , 2006, Nature.
[11] Y. Lau,et al. Pathogenesis of severe acute respiratory syndrome , 2005, Current Opinion in Immunology.
[12] Jun Xu,et al. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. , 2005, American journal of respiratory and critical care medicine.
[13] Anil T Ahuja,et al. Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. , 2003, Radiology.
[14] L. Malmgaard. Induction and regulation of IFNs during viral infections. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[15] Arul Earnest,et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. , 2003, JAMA.
[16] M. Loeb,et al. Early diagnosis of SARS: lessons from the Toronto SARS outbreak , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[17] Tzu-Hao Wang,et al. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV) , 2005, BMC Genomics.
[18] B. Williams,et al. Functional classification of interferon‐stimulated genes identified using microarrays , 2001, Journal of leukocyte biology.
[19] John L. Sullivan,et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.
[20] Peter Cameron,et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.
[21] J. Sung,et al. Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. , 2003, Radiology.
[22] A. Danchin,et al. The Severe Acute Respiratory Syndrome , 2003 .
[23] J. Sung,et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis , 2003, BMJ : British Medical Journal.
[24] Renji Reghunathan,et al. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome , 2005, BMC Immunology.
[25] Y. Guan,et al. Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis , 2005, Journal of Virology.
[26] S. Asa,et al. Pulmonary pathology of severe acute respiratory syndrome in Toronto , 2005, Modern Pathology.
[27] L. Poon,et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .
[28] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[29] J. Sung,et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.
[30] J. Sung,et al. Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome , 2005, Clinical chemistry.
[31] D. Fisher,et al. Preventing local transmission of SARS: lessons from Singapore , 2003, The Medical journal of Australia.
[32] M. Cameron,et al. Gene Expression Profiling of Host Response in Models of Acute HIV Infection1 , 2004, The Journal of Immunology.
[33] Zheng-hong Yuan,et al. Gene expression profiles in peripheral blood mononuclear cells of SARS patients. , 2005, World journal of gastroenterology.
[34] Pan‐Chyr Yang,et al. Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome , 2006, Respirology.
[35] C. Agrati,et al. Coordinate induction of IFN-α and -γ by SARS-CoV also in the absence of virus replication , 2005, Virology.
[36] P. Österlund,et al. Severe Acute Respiratory Syndrome Coronavirus Fails To Activate Cytokine-Mediated Innate Immune Responses in Cultured Human Monocyte-Derived Dendritic Cells , 2005, Journal of Virology.
[37] Paul Garner,et al. SARS: Systematic Review of Treatment Effects , 2006, PLoS medicine.
[38] Henry Y. H. Huang,et al. Radiographic-clinical correlation in severe acute respiratory syndrome: study of 1373 patients in Hong Kong. , 2005, Radiology.
[39] M. Salto‐Tellez,et al. ARDS in SARS: cytokine mediators and treatment implications , 2004, Cytokine.
[40] Ding-Mei Zhang,et al. Pathogenesis of severe acute respiratory syndrome. , 2008, Chinese medical journal.